Loading...
Stereotaxis, Inc.
STXS•AMEX
Healthcare
Medical - Instruments & Supplies
$2.25
$0.010(0.45%)
Stereotaxis, Inc. (STXS) Financial Performance & Income Statement Overview
Review Stereotaxis, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.55%
↑ 0.55%
Operating Income Growth
-13.28%
↓ 13.28%
Net Income Growth
-16.09%
↓ 16.09%
Operating Cash Flow Growth
7.02%
↑ 7.02%
Operating Margin
-94.23%
↓ 94.23%
Gross Margin
53.41%
↑ 53.41%
Net Profit Margin
-93.33%
↓ 93.33%
ROE
-217.13%
↓ 217.13%
ROIC
-120.70%
↓ 120.70%
Stereotaxis, Inc. (STXS) Income Statement & Financial Overview
Review Stereotaxis, Inc.'s (STXS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $6.34M | $9.20M | $4.50M | $6.88M |
| Cost of Revenue | $3.12M | $5.10M | $1.19M | $2.91M |
| Gross Profit | $3.22M | $4.10M | $3.31M | $3.97M |
| Gross Profit Ratio | $0.51 | $0.45 | $0.74 | $0.58 |
| R&D Expenses | $2.79M | $2.45M | $2.27M | $2.24M |
| SG&A Expenses | $8.05M | $7.99M | $7.06M | $6.47M |
| Operating Expenses | $10.84M | $10.44M | $9.33M | $8.71M |
| Total Costs & Expenses | $13.97M | $15.54M | $10.52M | $11.63M |
| Interest Income | $114000.00 | $150000.00 | $191000.00 | $239000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $363000.00 | $330000.00 | $136000.00 | $140000.00 |
| EBITDA | -$7.26M | -$5.86M | -$5.88M | -$4.61M |
| EBITDA Ratio | -$1.15 | -$0.64 | -$1.31 | -$0.67 |
| Operating Income | -$7.63M | -$6.34M | -$6.02M | -$4.75M |
| Operating Income Ratio | -$1.20 | -$0.69 | -$1.34 | -$0.69 |
| Other Income/Expenses (Net) | -$212000.00 | $155000.00 | $188000.00 | $239000.00 |
| Income Before Tax | -$7.84M | -$6.19M | -$5.83M | -$4.51M |
| Income Before Tax Ratio | -$1.24 | -$0.67 | -$1.30 | -$0.66 |
| Income Tax Expense | -$324000.00 | $0.00 | $0.00 | $96724.00 |
| Net Income | -$7.51M | -$6.19M | -$5.83M | -$4.51M |
| Net Income Ratio | -$1.19 | -$0.67 | -$1.30 | -$0.66 |
| EPS | -$0.08 | -$0.08 | -$0.07 | -$0.05 |
| Diluted EPS | -$0.08 | -$0.08 | -$0.07 | -$0.05 |
| Weighted Avg Shares Outstanding | $86.83M | $85.82M | $84.57M | $83.48M |
| Weighted Avg Shares Outstanding (Diluted) | $86.83M | $85.82M | $84.57M | $83.48M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan